强生召回泰诺林、美林等药物，FDA强烈建议暂时停止使用该药物

泰诺林、美林口服液，还有仙特明滴剂等已经被FDA建议暂时停用
  ^6 X7 X8 P* w: t
" T5 D7 g; h0 [9 I看报道似乎是制造工艺或者生产过程中的问题

2 {$ H: c$ w$ c5 G$ B) j2 N这几个药物在儿童中使用非常广泛

此次召回不知道是否包含中国？
; U- d9 q0 T7 S+ M' u: r) B' V
+ H* I9 |4 M* V! U-------------------------------------------

) e+ V7 n; k; g; I% y" i+ C& J2 iJohnson & Johnson's recalls infant, children's Tylenol, Motrin

) M4 O/ @: B, F' J' M; O  RSun May 2, 2010 1:37am EDT
(Reuters) - The Food and Drug Administration on Saturday urged consumers to stop using liquid Tylenol, Motrin, Benadryl and Zyrtec medicines for children and infants after a broad recall announced by the manufacturer, although it said the chance of serious problems was remote.
0 J* k8 S) ?# {. g1 b
U.S. | HEALTH
2 W* i: i" T+ A# Y
' M% z  O% ~9 n7 \Johnson & Johnson's consumer division announced a broad recall of products, including certain liquid infant's and children's Tylenol, Motrin, Zyrtec, and Benadryl products late on Friday.

A full list of the over 40 affected products made by McNeil Consumer Healthcare is available at www.mcneilproductrecall.com

- Z; B. }, }* Y6 C- x& b* p5 N) W$ ]"We want to be certain that consumers discontinue using these products," FDA Commissioner Margaret Hamburg said in a statement.

"While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality. We are investigating the products and facilities associated with this recall and will provide updates as we learn more," she said.
9 }# \  g2 X& @. A7 v, P$ q
! }, |5 q; W; @McNeil said it was recalling the products in consultation with the FDA after discovering manufacturing deficiencies that could affect the quality, purity or potency of the medicines.

. U$ H+ C& \8 e* J+ L' d' NThe FDA said some of the products may not meet required quality standards, and parents and caregivers should stop administering them to children and switch to generic brands, which are not affected by the recall.

They said consumers should not administer adult strength medicine to infants or children since that could result in serious harm.

Some of the products affected by the recall may contain a higher concentration of active ingredient than specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles, the FDA said.

0 E1 s8 V! `6 W+ `/ lThe FDA said the chance of an adverse reaction was remote, but urged consumers to contact their doctors and the FDA if their children exhibited any symptoms.
1 Z8 r8 V/ |' }4 W- m
McNeil Consumer said it was recalling all lots of the over-the-counter products. The medicines were manufactured in the United States and distributed in the United States, Canada, the Dominican Republic, Dubai, Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad and Tobago, and Kuwait.

% l+ J; ]$ s" g# YIt said consumers with questions about the recall could contact the company at 1-800-222-6036 or the website.

强生公司召回儿童用泰诺和美林
(Reuters) - The Food and Drug Administration on Saturday urged consumers to stop using liquid Tylenol, Motrin, Benadryl and Zyrtec medicines for children and infants after a broad recall announced by the manufacturer, although it said the chance of serious problems was remote.

U.S. | Health

% j5 U+ |" ^0 a+ [# y9 VJohnson & Johnson's consumer division announced a broad recall of products, including certain liquid infant's and children's Tylenol, Motrin, Zyrtec, and Benadryl products late on Friday.
$ ]- s( ]. \- M6 M& J" ~
) ^5 i. d7 h1 \! FA full list of the over 40 affected products made by McNeil Consumer Healthcare is available at www.mcneilproductrecall.com

& v) U( X  m3 Z4 T( n, F) j* m1 g) _"We want to be certain that consumers discontinue using these products," FDA Commissioner Margaret Hamburg said in a statement.
6 q) O6 V/ S6 s
"While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality. We are investigating the products and facilities associated with this recall and will provide updates as we learn more," she said.

McNeil said it was recalling the products in consultation with the FDA after discovering manufacturing deficiencies that could affect the quality, purity or potency of the medicines.
, u* }2 C: N% T# e( j
The FDA said some of the products may not meet required quality standards, and parents and caregivers should stop administering them to children and switch to generic brands, which are not affected by the recall.

+ H! ]3 E* X& f/ o1 H' ?They said consumers should not administer adult strength medicine to infants or children since that could result in serious harm.
# D; W4 S) d  F* p+ I
) k6 B0 S& \7 c' [# _Some of the products affected by the recall may contain a higher concentration of active ingredient than specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles, the FDA said.

The FDA said the chance of an adverse reaction was remote, but urged consumers to contact their doctors and the FDA if their children exhibited any symptoms.

. s+ r3 f& A1 ?0 s4 Q' p/ @3 D9 q, Y9 IMcNeil Consumer said it was recalling all lots of the over-the-counter products. The medicines were manufactured in the United States and distributed in the United States, Canada, the Dominican Republic, Dubai, Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad and Tobago, and Kuwait.

It said consumers with questions about the recall could contact the company at 1-800-222-6036 or the website.

(Reporting by Andrea Shalal-Esa; Editing by Eric Beech)

http://www.reuters.com/article/i ... +/+US+/+Health+News